<DOC>
	<DOCNO>NCT02386332</DOCNO>
	<brief_summary>This open-label , prospective , observational , multicenter , randomize study compare efficacy unrelated umbilical cord blood transplantation ( UCBT ) HLA-haploidentical related hematopoietic stem cell transplantation , myeloablative conditioning adult patient hematologic malignancy .</brief_summary>
	<brief_title>A Randomized Multicenter Study Compare Two Types Transplant Adult Patients With Hematologic Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>1 . Age : subject ≥ 18 ≤ 55 year old . 2 . Patients without suitable match related donor 3 . Diagnosed acute leukemia myelodysplastic syndrome allogeneic transplantation consider potentially curative therapeutic option . 4 . Written consent form sign . Performance status : Eastern Cooperative Oncology Group ( ECOG ) score &gt; 2 Prior allogenic hematopoietic stem cell transplant Leftventricular ejection fraction rest &lt; 45 % , uncontrolled arrhythmia symptomatic heart failure . Diffusing capacity ( DLCO ) and/or force vital capacity ( FVC ) &lt; 39 % predict value symptomatic pulmonary disease Altered liver function test ( total bilirubin &gt; 2 mg/dL and/or alanine aminotransferase , aspartate aminotransferase , active hepatitis cirrhosis . Serum creatinine &gt; 2 mg/dL estimate creatinine clearance &lt; 50 mL/min Evidence uncontrolled bacterial , viral fungal infection prior condition regimen Serious disease prevent patient receive chemotherapy treatment . Concomitant neoplasm . Pregnancy breastfeed . Any medical , surgical psychiatric condition consider attend and/or medical team contraindication intensive treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>